{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:17:34Z","timestamp":1793146654144,"version":"4.5.0"},"reference-count":38,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hereditary thrombotic thrombocytopenic purpura (hTTP) is a rare thrombotic microangiopathy characterized by severe congenital ADAMTS13 deficiency and recurring acute episodes causing morbidity and premature death. Information on the annual incidence and severity of acute episodes in patients with hTTP is largely lacking. This study reports prospective data on 87 patients from the Hereditary TTP Registry (clinicaltrials.gov #NCT01257269) for survival, frequency, and severity of acute episodes from enrollment until December 2019. The 87 patients, followed up for a median of 4.2 years (range, 0.01-15 years), had a median age at overt disease onset and at clinical diagnosis of 4.6 years and 18 years (range, 0.0-70 years for both), respectively. Forty-three patients received regular plasma prophylaxis, whereas 22 did not, and treatment changed over time or was unknown in the remaining 22. Forty-three patients experienced 131 acute episodes, of which 91 (69%) occurred in patients receiving regular prophylaxis. This resulted in an annual incidence of acute episodes of 0.36 (95% confidence interval [CI], 0.29-0.44) with regular plasma treatment and of 0.41 (95% CI, 0.30-0.56) without regular plasma treatment. More than one-third of acute episodes (n = 51) were documented in children &amp;lt;10 years of age at enrollment and were often triggered by infections. Their annual incidence of acute episodes was significantly higher than in patients aged &amp;gt;40 years (1.18 [95% CI, 0.88-1.55] vs 0.14 [95% CI, 0.08-0.23]). The prophylactic plasma infusion regimens used were insufficient to prevent acute episodes in many patients. Such regimens are burdensome, and caregivers, patients, and their guardians are reluctant to start regular plasma infusions, from which children particularly would benefit.<\/jats:p>","DOI":"10.1182\/blood.2020009801","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T22:53:47Z","timestamp":1614639227000},"page":"3563-3575","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":72,"title":["Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura"],"prefix":"10.1182","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-8476","authenticated-orcid":false,"given":"Erika","family":"Tarasco","sequence":"first","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"},{"name":"Department for BioMedical Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0801-746X","authenticated-orcid":false,"given":"Lukas","family":"B\u00fctikofer","sequence":"additional","affiliation":[{"name":"CTU Bern, University of Bern, Bern, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-407X","authenticated-orcid":false,"given":"Kenneth D.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4243-2691","authenticated-orcid":false,"given":"James N.","family":"George","sequence":"additional","affiliation":[{"name":"Department of Biostatistics & Epidemiology, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Hrachovinova","sequence":"additional","affiliation":[{"name":"NRL for Hemostasis, Institute of Hematology and Blood Transfusion, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7909-7225","authenticated-orcid":false,"given":"Paul N.","family":"Kn\u00f6bl","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hemostasis, Department of Medicine I, Medical University of Vienna, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7243-3126","authenticated-orcid":false,"given":"Masanori","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sophie","family":"von Krogh","sequence":"additional","affiliation":[{"name":"Department of Hematology, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway;"},{"name":"Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Aebi-Huber","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"},{"name":"Department for BioMedical Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3495-5660","authenticated-orcid":false,"given":"Zuzana","family":"Cermakova","sequence":"additional","affiliation":[{"name":"Blood Center, University Hospital Ostrava, Ostrava, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"G\u00f3rska-Kosicka","sequence":"additional","affiliation":[{"name":"Department of Haemostasis Disorders and Internal Medicine Institute of Hematology and Transfusion Medicine, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3284-8308","authenticated-orcid":false,"given":"Katarzyna A.","family":"Jalowiec","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0889-8922","authenticated-orcid":false,"given":"Carlo R.","family":"Largiad\u00e8r","sequence":"additional","affiliation":[{"name":"University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, Bern, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1761-7982","authenticated-orcid":false,"given":"Zolt\u00e1n","family":"Proh\u00e1szka","sequence":"additional","affiliation":[{"name":"Research Laboratory, Department of Internal Medicine and Hematology, and Research Group for Immunology and Hematology, E\u00f6tv\u00f6s Lor\u00e1nd Research Network and Semmelweis University, Budapest, Hungary; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5355-7318","authenticated-orcid":false,"given":"Gy\u00f6rgy","family":"Sinkovits","sequence":"additional","affiliation":[{"name":"Research Laboratory, Department of Internal Medicine and Hematology, and Research Group for Immunology and Hematology, E\u00f6tv\u00f6s Lor\u00e1nd Research Network and Semmelweis University, Budapest, Hungary; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7877-4784","authenticated-orcid":false,"given":"Jerzy","family":"Windyga","sequence":"additional","affiliation":[{"name":"Department of Haemostasis Disorders and Internal Medicine Institute of Hematology and Transfusion Medicine, Warsaw, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4538-5154","authenticated-orcid":false,"given":"Bernhard","family":"L\u00e4mmle","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"},{"name":"Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1300-7135","authenticated-orcid":false,"given":"Johanna A.","family":"Kremer Hovinga","sequence":"additional","affiliation":[{"name":"Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"},{"name":"Department for BioMedical Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10","key":"2021062415255315900_B1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"issue":"21","key":"2021062415255315900_B2","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"issue":"17","key":"2021062415255315900_B3","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMra1813013","article-title":"Hereditary thrombotic thrombocytopenic purpura","volume":"381","author":"Kremer Hovinga","year":"2019","journal-title":"N Engl J Med"},{"issue":"6855","key":"2021062415255315900_B4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","article-title":"Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura","volume":"413","author":"Levy","year":"2001","journal-title":"Nature"},{"issue":"suppl 1","key":"2021062415255315900_B5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1538-7836.2011.04341.x","article-title":"Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan","volume":"9","author":"Fujimura","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2021062415255315900_B6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/blood-2012-01-403113","article-title":"Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura","volume":"120","author":"Lotta","year":"2012","journal-title":"Blood"},{"issue":"15","key":"2021062415255315900_B7","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1182\/blood-2018-11-884700","article-title":"Characterization and treatment of congenital thrombotic thrombocytopenic purpura","volume":"133","author":"Alwan","year":"2019","journal-title":"Blood"},{"issue":"10","key":"2021062415255315900_B8","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3324\/haematol.2019.216796","article-title":"The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017","volume":"104","author":"van Dorland","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"2021062415255315900_B9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/jth.13186","article-title":"High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence","volume":"14","author":"von Krogh","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2021062415255315900_B10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1053\/beha.2001.0142","article-title":"Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease","volume":"14","author":"Furlan","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"2021062415255315900_B11","first-page":"709","article-title":"Genetic and functional characterization of ADAMTS13 variants in a patient cohort with Upshaw-Schulman syndrome investigated in Germany","volume":"118","author":"Hassenpflug","year":"2018","journal-title":"Thromb Haemost"},{"issue":"4","key":"2021062415255315900_B12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/ejh.13107","article-title":"Pediatric thrombotic thrombocytopenic purpura","volume":"101","author":"Joly","year":"2018","journal-title":"Eur J Haematol"},{"issue":"5","key":"2021062415255315900_B13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2141.2008.07515.x","article-title":"Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients","volume":"144","author":"Fujimura","year":"2009","journal-title":"Br J Haematol"},{"issue":"24","key":"2021062415255315900_B14","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","article-title":"Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura","volume":"119","author":"Moatti-Cohen","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2021062415255315900_B15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/blood-2014-02-553131","article-title":"Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes","volume":"124","author":"Scully","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2021062415255315900_B16","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1160\/TH13-08-0713","article-title":"The impact of congenital thrombotic thrombocytopenic purpura on pregnancy complications","volume":"111","author":"von Krogh","year":"2014","journal-title":"Thromb Haemost"},{"issue":"1","key":"2021062415255315900_B17","first-page":"39","article-title":"Inherited thrombotic thrombocytopenic purpura (Upshaw Schulman syndrome) as differential diagnosis to neonatal septicaemia with disseminated intravascular coagulation\u2014a case series","volume":"221","author":"Lehmberg","year":"2017","journal-title":"Z Geburtshilfe Neonatol"},{"issue":"21","key":"2021062415255315900_B18","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/bloodadvances.2019000601","article-title":"Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome","volume":"3","author":"Fujimura","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"2021062415255315900_B19","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1538-7836.2005.01768.x","article-title":"Desmopressin, an unexpected link between nocturnal enuresis and inherited thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome)","volume":"4","author":"Veyradier","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"23","key":"2021062415255315900_B20","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1182\/bloodadvances.2019000959","article-title":"Stroke and myocardial infarction in hereditary thrombotic thrombocytopenic purpura: similarities to sickle cell anemia","volume":"3","author":"Borogovac","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"2021062415255315900_B21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1365-2141.2001.02808.x","article-title":"Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease","volume":"113","author":"Barbot","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"2021062415255315900_B22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jca.21664","article-title":"ADAMTS13 kinetics after therapeutic plasma exchange and plasma infusion in patients with Upshaw-Schulman syndrome","volume":"34","author":"Kovarova","year":"2019","journal-title":"J Clin Apher"},{"issue":"2","key":"2021062415255315900_B23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5482\/HAMO-13-04-0026","article-title":"Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry","volume":"33","author":"Mansouri Taleghani","year":"2013","journal-title":"Hamostaseologie"},{"issue":"2","key":"2021062415255315900_B24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2021062415255315900_B25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3324\/haematol.2011.051433","article-title":"Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura","volume":"97","author":"Froehlich-Zahnd","year":"2012","journal-title":"Haematologica"},{"issue":"1","key":"2021062415255315900_B26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","article-title":"FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay","volume":"129","author":"Kokame","year":"2005","journal-title":"Br J Haematol"},{"issue":"3","key":"2021062415255315900_B27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"2021062415255315900_B28","first-page":"247","article-title":"WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976","volume":"56","author":"WHO","year":"1977","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9832","key":"2021062415255315900_B29","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"2021062415255315900_B30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/hae.13325","article-title":"Can you grow out of von Willebrand disease?","volume":"23","author":"Laffan","year":"2017","journal-title":"Haemophilia"},{"issue":"25","key":"2021062415255315900_B31","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1182\/blood-2015-05-643338","article-title":"Low ADAMTS13 activity is associated with an increased risk of ischemic stroke","volume":"126","author":"Sonneveld","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2021062415255315900_B32","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/ATVBAHA.116.308225","article-title":"Von Willebrand factor, ADAMTS13, and the risk of mortality: the Rotterdam Study","volume":"36","author":"Sonneveld","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2021062415255315900_B33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tmrv.2018.08.002","article-title":"Microangiopathic hemolytic anemia in pregnancy","volume":"32","author":"Neave","year":"2018","journal-title":"Transfus Med Rev"},{"issue":"6","key":"2021062415255315900_B34","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1016\/j.amjmed.2019.01.016","article-title":"Clinician\u2019s guide to the updated ABCs of cardiovascular disease prevention: a review part 1","volume":"132","author":"Arps","year":"2019","journal-title":"Am J Med"},{"issue":"7","key":"2021062415255315900_B35","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1016\/j.amjmed.2019.01.031","article-title":"Clinician\u2019s guide to the updated ABCs of cardiovascular disease prevention: a review part 2","volume":"132","author":"Arps","year":"2019","journal-title":"Am J Med"},{"issue":"6","key":"2021062415255315900_B36","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"issue":"13","key":"2021062415255315900_B37","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-01-528414","article-title":"Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens","volume":"125","author":"Oldenburg","year":"2015","journal-title":"Blood"},{"issue":"19","key":"2021062415255315900_B38","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2017-06-788026","article-title":"Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura","volume":"130","author":"Scully","year":"2017","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/25\/3563\/1810725\/bloodbld2020009801.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/25\/3563\/1810725\/bloodbld2020009801.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T11:27:12Z","timestamp":1624534032000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/137\/25\/3563\/475390\/Annual-incidence-and-severity-of-acute-episodes-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":38,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2021,6,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020009801","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]}}}